YBX1 and esophageal squamous cell carcinoma: Our findings highlight the crucial role of YBX1 in tumorigenesis and metastasis of ESCC and provide a preclinical rationale for selectively targeting YBX1‐mediated m5C recognition as a promising therapeutic strategy for ESCC.